Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00369746 · ClinicalTrials.gov registry record

STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse

A clinical trial, sponsored by New York State Psychiatric Institute.

Completed
Registry status
674
Enrollment target

NCT00369746: Completed study, sponsored by New York State Psychiatric Institute.

NCT00369746 is a clinical trial that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 674 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00369746 has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
674 participants
Enrollment target

Study Summary

The purpose of this study is to determine if having an alcohol use disorder affects recovery from depression, and also whether recovery from depression in patients who have alcohol use disorders is also accompanied by improvement in the alcohol use disorder.

Primary Outcome

Quick Inventory of Depression- Self Report assesses 16 depressive symptoms experienced in the past week, based on self-rating, measured at study exit visit Scale range: Each of the four possible answers to each quiz is given an ascending numerical value from 0 to 3, and the total test score is the sum of the following: The highest number from questions 1-4 The number from question 5 The highest number from questions 6-9 The total of each question from 10-14 The highest number from questions 15

Interventions

  • DRUG citalopram

Trial Details

FieldValue
Enrollment Target 674 participants
Start Date 2006-09
Est. Completion 2009-02

What the finished NCT00369746 record still lists

NCT00369746 is an observational study that tracks outcomes without assigning an intervention. The registered 674 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which citalopram is the first listed.

NCT00369746 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00369746 about?

NCT00369746 is a clinical study titled "STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse". The purpose of this study is to determine if having an alcohol use disorder affects recovery from depression, and also whether recovery from depression in patients who have alcohol use disorders is also accompanied by improvement in the alcohol use disorder.

What is the current status of trial NCT00369746?

This trial is currently completed. The enrollment target is 674 participants. The study started on 2006-09. Estimated completion is 2009-02.

What interventions are being tested in trial NCT00369746?

The interventions under investigation include: citalopram (DRUG).

Who is sponsoring clinical trial NCT00369746?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06335381 · 674 participants · NA

    MOMs Chat and Care Study

  • NCT06757634 · 674 participants · Phase 3

    Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

  • NCT04788277 · 675 participants

    Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)

  • NCT05356234 · 675 participants · NA

    Ignite Study of the Jewish Family and Children's Service of the Suncoast, Inc.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00369746, the US trial registry maintained by the National Library of Medicine. NCT00369746 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.